What Happened?
Boston, MA-based Elucid Appointed Andrew Miller as Chief Technology Officer
Date of management change: March 28, 2023
Boston, MA-based Elucid Appointed Andrew Miller as Chief Technology Officer
Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid equips physicians with critical information designed to enable precision medicine. Elucid is the first FDA-Cleared and CE-marked non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall and estimation of coding and non-coding RNA transcripts (“Virtual Transcriptomics”). This unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs. The Elucid software is available for commercial use in the U.S. and Europe
Andrew Miller is Chief Technology Officer at Elucid. Previously, Andrew held various senior IT leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Howell Kit, Moya Marc, Shepherd Matt, Culler Aaron, Medlin Lisa, Mancinelli Paul, Meyer David, Raahauge Ginna, Bradbury David, Lawless Stefanie, Perpignan Cristal
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.